Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy

Open access
Bhatraju, Pavan K., Zelnick, Leila R., Herting, Jerald, Katz, Ronit, Mikacenic, Carmen, Kosamo, Susanna, Morrell, Eric D., Robinson-Cohen, Cassianne, Calfee, Carolyn S., Christie, Jason D., Liu, Kathleen D., Matthay, Michael A., Hahn, William O., Dmyterko, Victoria, Slivinski, Natalie S. J., Russell, Jim A., Walley, Keith R., Christiani, David C., Liles, W. Conrad, Himmelfarb, Jonathan, Wurfel, Mark M. · 2019 · American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Currently, no safe and effective pharmacologic interventions exist for acute kidney injury (AKI). One reason may be that heterogeneity exists within the AKI population, thereby hampering the identification of specific pathophysiologic pathways and therapeutic targets. OBJECTIVE: The aim of this study was to identify and test whether AKI subphenotypes have prognostic and therapeutic implications. METHODS: First, latent class analysis methodology was applied independently in two critically ill populations (discovery [n = 794] and replication [n = 425]) with AKI. Second, a parsimonious classification model was developed to identify AKI subphenotypes. Third, the classification model was applied to patients with AKI in VASST (Vasopressin and Septic Shock Trial; n = 271), and differences in treatment response were determined. In all three populations, AKI was defined using serum creatinine and urine output. MEASUREMENTS AND MAIN RESULTS: A two-subphenotype latent class analysis model had the best fit in both the discovery (P = 0.004) and replication (P = 0.004) AKI groups. The risk of 7-day renal nonrecovery and 28-day mortality was greater with AKI subphenotype 2 (AKI-SP2) relative to AKI subphenotype 1 (AKI-SP1). The AKI subphenotypes discriminated risk for poor clinical outcomes better than the Kidney Disease: Improving Global Outcomes stages of AKI. A three-variable model that included markers of endothelial dysfunction and inflammation accurately determined subphenotype membership (C-statistic 0.92). In VASST, vasopressin compared with norepinephrine was associated with improved 90-day mortality in AKI-SP1 (27% vs. 46%, respectively; P = 0.02), but no significant difference was observed in AKI-SP2 (45% vs. 49%, respectively; P = 0.99) and the P value for interaction was 0.05. CONCLUSIONS: This analysis identified two molecularly distinct AKI subphenotypes with different clinical outcomes and responses to vasopressin therapy. Identification of AKI subphenotypes could improve risk prognostication and may be useful for predictive enrichment in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201807-1346oc

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 207

Metadata

Authors
Bhatraju, P. K., Zelnick, L. R., Herting, J., Katz, R., Mikacenic, C., Kosamo, S., Morrell, E. D., Robinson-Cohen, C., Calfee, C. S., Christie, J. D., Liu, K. D., Matthay, M. A., Hahn, W. O., Dmyterko, V., Slivinski, N. S. J., Russell, J. A., Walley, K. R., Christiani, D. C., Liles, W. C., Himmelfarb, J., & Wurfel, M. M.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2019-04-01
Volume
199
Issue
7
Pages
863-872
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2896434545
Cited by
207
References
8
FWCI
8.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy. https://app.cochat.ai/papers/10.1164/rccm.201807-1346oc
The paper
Bhatraju, P. K., Zelnick, L. R., Herting, J., Katz, R., Mikacenic, C., Kosamo, S., Morrell, E. D., Robinson-Cohen, C., Calfee, C. S., Christie, J. D., Liu, K. D., Matthay, M. A., Hahn, W. O., Dmyterko, V., Slivinski, N. S. J., Russell, J. A., Walley, K. R., Christiani, D. C., Liles, W. C., . . . Wurfel, M. M. (2019). Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201807-1346oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.